| Haven Convalescent Home, Inc | |
| 725 Paul Street, New Castle, Pennsylvania 16101 | |
| (724) 654-8833 | |
| Name | Haven Convalescent Home, Inc |
|---|---|
| Location | 725 Paul Street, New Castle, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 91 |
| Occupancy Rate | 98.13% |
| Medicare ID (CCN) | 396106 |
| Legal Business Name | Haven Convalescent Home, Inc. |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India - one of the world's most ethnically diverse countries.
Scientists at Burnham Institute for Medical Research have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer cells to proliferate, migrate and invade surrounding tissues. The study was published in the journal Cancer Research on June 15.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
The body's brown fat cells play a key role in the development of obesity and diabetes. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have now discovered that we humans have two different kinds of brown fat cells and not one kind as previously thought.
Approximately 2 million people, including 400,000 children, in the United States are being treated for epilepsy, and one-third continue to have seizures despite treatment. In order to address an important caregiver need, RTI International has been developing a prototype mobile seizure alert system to help epilepsy patients and their families cope with seizures.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.93 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 5.45 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 39.82 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.65 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.91 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.99 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 17.02 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.73 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.36 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 24.6 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.2 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 12.2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.72 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 48.23 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.59 | 82.93 |
News Archive
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India - one of the world's most ethnically diverse countries.
Scientists at Burnham Institute for Medical Research have found that the Caspase-8 protein, long known to play a major role in promoting programmed cell death (apoptosis), helps relay signals that can cause cancer cells to proliferate, migrate and invade surrounding tissues. The study was published in the journal Cancer Research on June 15.
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
The body's brown fat cells play a key role in the development of obesity and diabetes. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have now discovered that we humans have two different kinds of brown fat cells and not one kind as previously thought.
Approximately 2 million people, including 400,000 children, in the United States are being treated for epilepsy, and one-third continue to have seizures despite treatment. In order to address an important caregiver need, RTI International has been developing a prototype mobile seizure alert system to help epilepsy patients and their families cope with seizures.
› Verified 7 days ago
Quality Life Services - New Castle Location: 520 Friendship Street, New Castle, Pennsylvania 16101 Phone: (412) 654-7791 | |
Grove At New Castle, The Location: 715 Harbor Street, New Castle, Pennsylvania 16101 Phone: (724) 652-3863 | |
Edison Manor Nursing & Rehabilitation Center Location: 222 West Edison Avenue, New Castle, Pennsylvania 16101 Phone: (724) 652-6340 | |
Jameson Care Center Location: 3349 Wilmington Road, New Castle, Pennsylvania 16105 Phone: (724) 598-3300 | |
Haven Convalescent Home, Inc Location: 725 Paul Street, New Castle, Pennsylvania 16101 Phone: (724) 654-8833 |